+Search query
-Structure paper
Title | Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate. |
---|---|
Journal, issue, pages | PLoS Pathog, Vol. 20, Issue 11, Page e1012726, Year 2024 |
Publish date | Nov 26, 2024 |
Authors | Gang Ye / Fan Bu / Divyasha Saxena / Hailey Turner-Hubbard / Morgan Herbst / Benjamin Spiller / Brian E Wadzinski / Lanying Du / Bin Liu / Jian Zheng / Fang Li / |
PubMed Abstract | Omicron subvariants of SARS-CoV-2 continue to pose a significant global health threat. Nanobodies, single-domain antibodies derived from camelids, are promising therapeutic tools against pandemic ...Omicron subvariants of SARS-CoV-2 continue to pose a significant global health threat. Nanobodies, single-domain antibodies derived from camelids, are promising therapeutic tools against pandemic viruses due to their favorable properties. In this study, we identified a novel nanobody, Nanosota-9, which demonstrates high potency against a wide range of Omicron subvariants both in vitro and in a mouse model. Cryo-EM data revealed that Nanosota-9 neutralizes Omicron through a unique mechanism: two Nanosota-9 molecules crosslink two receptor-binding domains (RBDs) of the trimeric Omicron spike protein, preventing the RBDs from binding to the ACE2 receptor. This mechanism explains its strong anti-Omicron potency. Additionally, the Nanosota-9 binding epitopes on the spike protein are relatively conserved among Omicron subvariants, contributing to its broad anti-Omicron spectrum. Combined with our recently developed structure-guided in vitro evolution approach for nanobodies, Nanosota-9 has the potential to serve as the foundation for a superior anti-Omicron therapeutic. |
External links | PLoS Pathog / PubMed:39591462 / PubMed Central |
Methods | EM (single particle) |
Resolution | 2.99 - 3.44 Å |
Structure data | EMDB-45771, PDB-9co6: EMDB-45772, PDB-9co7: EMDB-45773, PDB-9co8: EMDB-45774, PDB-9co9: |
Chemicals | ChemComp-NAG: |
Source |
|
Keywords | VIRAL PROTEIN / spike / nanobody / VIRAL PROTEIN/IMMUNE SYSTEM / VIRAL PROTEIN-IMMUNE SYSTEM complex / EBOV glycoprotein |